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Next-generation DNA sequencing (NGS) has revolution-
ized  genetics  by  enabling  researchers  to  routinely 
sequence  genomes,  either  in  their  entirety  or  specific 
subsets [1-3]. For example, exome resequencing, in which 
researchers enrich for all annotated and putative exons 
and then sequence the genomic targets, has been widely 
adopted.  Exome  sequencing  has  become  a  popular 
approach owing to the availability of commercial exome 
enrichment assays, the generally lower cost than whole-
genome sequencing and the focus on coding regions and 
associated variants that have a direct impact on coding 
sequence  and  thus  gene  function.  As  a  result,  a  large 
number of studies are using human exome resequencing 
to  study  the  genetic  diversity  of  human  populations. 
Furthermore, exome resequencing is frequently used in 
the study of human diseases, including Mendelian dis-
orders  and  cancer.  Given  the  accessibility  of  the  tech-
nology,  many  groups  are  working  towards  potential 
clinical diagnostic applications in personalized medicine.
Challenges of variant calling from exome 
sequencing
Analysis has become one of the primary challenges for 
NGS  users,  as  a  direct  result  of  the  sheer  volume  of 
sequencing  data  currently  being  generated.  Exome 
sequence analysis can be generally summarized as a two 
step  process  with  alignment  of  the  data  to  a  human 
genome reference followed by subsequent genetic variant 
calling from the post-alignment data, or, more simply, the 
identification  of  specific  sequence  alterations  that  are 
polymorphisms,  rare  variants  or  mutations.  Exome-
targeted resequencing analysis is particularly useful for 
the  discovery  of  single  nucleotide  variants  (SNVs)  and 
insertion  or  deletions  (indels).  Although  a  variety  of 
robust and now widely adopted sequence alignment tools 
are available, the challenge of variant calling from aligned 
data  remains.  Although  alignment  algorithms  can  be 
used to accurately determine the location of any sequence, 
it is more problematic to determine whether a variation 
that is identified in an aligned sequence is a true genetic 
variation.  Numerous  academic  and  commercial  groups 
have developed a variety of bioinformatic tools or cloud-
based solutions to facilitate variant calling. For example, 
SAMtools [4] and the Genome Analysis Tool Kit (GATK) 
[5] provide SNV and indel calling and are widely used. 
However, experienced bioinformaticians and information 
technology specialists are required to implement these 
and other popular tools, limiting accessibility of variant 
calling  for  the  research  community  and  in  clinical 
diagnostic  laboratories.  In  addition,  the  accuracy  of 
variant  calling  bioinformatic  tools  is  highly  variable. 
Improving the speed, accuracy and user-friendliness of 
sophisticated  variant  calling  pipelines  is  an  important 
step towards personalized medicine.
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for identifying variants in coding regions. However, 
recognizing the relevant single nucleotide variants, 
small insertions and deletions remains a challenge for 
many researchers and diagnostic laboratories typically 
do not have access to the bioinformatic analysis 
pipelines necessary for clinical application. The Atlas2 
suite, recently released by Baylor Genome Center, is 
designed to be widely accessible, runs on desktop 
computers but is scalable to computational clusters, 
and performs comparably with other popular variant 
callers. Atlas2 may be an accessible alternative for data 
processing when a rapid solution for variant calling is 
required.
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© 2012 BioMed Central LtdSeeking to address this challenge, Fuli Yu and colleagues 
from  the  Baylor  Genome  Center  recently  published  in 
BMC Bioinformatics a variant-calling software package, 
the  Atlas2  suite  [6],  that  can  analyze  aligned  data 
generated  from  a  variety  of  NGS  platforms,  including 
Life Sciences’ SOLiD, Roche’s 454 and Illumina’s Genome 
Analyzer and HiSeq systems. I focus on application of the 
Atlas2  suite  and  its  optimization  for  exome  sequence 
analysis. Atlas2 relies on the standard Binary Sequence 
Alignment/Mapping  format  (BAM)  sequence  format, 
which is a widely adopted and generally supported format 
among NGS users [4]. For example, this format is used 
for  cancer  exome  data  from  the  National  Institutes  of 
Health’s  repertoire  of  sequencing  production  studies 
such  as  the  Cancer  Genome  Atlas.  Variant  calls  are 
produced  using  the  Variant  Call  Format  (VCF),  which 
has been adopted by the 1000 Genomes Project. Atlas2 
runs on many different computing platforms, from the 
standard desktop computer to highly scaled implemen-
tation with multimode computational clusters. The group 
also  implemented  Atlas2  on  the  Genboree  Workbench 
[7], a genomic web resource that enables the user to view 
NGS  data  and  carry  out  analysis.  Web-driven  analysis 
tools  are  increasingly  popular,  as  seen  with  Galaxy [8] 
and DNANexus [9]. Given that most clinical diagnostic 
centers do not have a dedicated bioinformatics staff, the 
desktop computer and web implementation aspects have 
particular appeal for a diagnostic laboratory setting.
Developing and testing a variant calling algorithm
Challis et al. [6] used a trained logistic regression model 
to assess the quality of each potential variant as a true 
variant rather than a sequencing, mapping, or alignment 
error.  Critical  factors  that  they  assessed  include  the 
following:  ratio  of  the  variant  base  to  the  reference 
sequence, the overall sequencing depth, the quality scores 
of the base calls, and the position in the read and strand 
direction based on whether it is the forward or reverse 
sequence. These factors are well known to be important 
in  determining  the  accuracy  of  variant  calls  and,  not 
surprisingly,  were  the  most  significant  in  the  authors’ 
statistical analysis [6]. Ultimately, these variables were an 
important component of the statistical model driving the 
Atlas2 variant calling algorithm.
One of the challenges faced by any NGS variant caller 
is  the  introduction  of  false  positive  and  false  negative 
SNVs and indel calls. All variant callers and their related 
publications  typically  report  the  overall  sensitivity, 
specificity  and  false  discovery  rates  of  variants  called 
from a control genome. Atlas2 was compared with two 
other popular variant callers, GATK and SAMtools, using 
sequence data from the 1000 Genomes Project. For single 
nucleotide polymorphisms (SNPs), the group discovered 
that  Atlas2  had  a  generally  high  concordance  with 
reported SNP discovery. Overall, Atlas2 showed a signifi-
cantly  lower  number  of  indels  by  nearly  an  order  of 
magni  tude than either GATK or SAMtools, potentially 
because  of  higher  false  positive  rates  in  GATK  and 
SAMtools. For the analysis of Illumina sequencer data, 
Atlas2  indel  calls  were  comparable  to  those  of  Dindel 
[10],  an  indel  caller  considered  to  be  state-of-the-art, 
with a greater than 85% concordance rate.
The authors [6] also demonstrated that Atlas2 could be 
run on a desktop computer and that the analysis of a 28 
GB whole-exome BAM file takes only 2 hours. Interest-
ingly, they used a single core processor, whereas many 
current  desktop  computers  have  significantly  more 
processors, suggesting that even faster processing times 
could be achieved on newer and more powerful desktop 
computers. The implementation of Atlas2 on a compu  ta-
tional cluster enabled rapid processing and they cite a 
performance of running 92 exomes from 64 processors in 
4 hours. In my own experience, GATK requires a signi  fi-
cant  number  of  compute  nodes  to  process  exome 
sequence in days, rather than hours. The speed of analysis 
is a major strength of the Atlas2 suite and makes such 
analyses accessible to research groups analyzing exome 
data, even those who do not have routine access to large 
multiprocessor computational clusters.
Overall,  Challis  et  al.  [6]  have  introduced  a  highly 
flexible and rapid SNV, SNP and indel calling program 
suite.  It  uses  standard  data  formats  that  are  widely 
adopted. Most importantly, the flexibility of Atlas2 to run 
on  standard  desktop  computers  and  workstations  pro-
vides  an  opportunity  for  many  laboratories  to  use  the 
software.  Also,  in  comparison  studies  with  GATK, 
SAMTools and Dindel, Atlas2 demonstrated comparable 
variant  calling  accuracy,  showing  that  accuracy  is  not 
compromised by faster processing times. Given that this 
software is generally available and is open source, this 
represents  a  solution  that  could  be  readily  adopted  by 
many groups regardless of their size or resources.
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